Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

205 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Update on optimal use of omalizumab in management of asthma.
Pelaia G, Gallelli L, Renda T, Romeo P, Busceti MT, Grembiale RD, Maselli R, Marsico SA, Vatrella A. Pelaia G, et al. J Asthma Allergy. 2011;4:49-59. doi: 10.2147/JAA.S14520. Epub 2011 Jun 13. J Asthma Allergy. 2011. PMID: 21792319 Free PMC article.
Dupilumab: a novel treatment for asthma.
Vatrella A, Fabozzi I, Calabrese C, Maselli R, Pelaia G. Vatrella A, et al. Among authors: pelaia g. J Asthma Allergy. 2014 Sep 4;7:123-30. doi: 10.2147/JAA.S52387. eCollection 2014. J Asthma Allergy. 2014. PMID: 25214796 Free PMC article. Review.
Asthma management in a specialist setting: Results of an Italian Respiratory Society survey.
Braido F, Baiardini I, Alleri P, Bacci E, Barbetta C, Bellocchia M, Benfante A, Blasi F, Bucca C, Busceti MT, Centanni S, Colanardi MC, Contoli M, Corsico A, D'Amato M, Di Marco F, Marco D, Ferrari M, Florio G, Fois AG, Foschino Barbaro MP, Silvia G, Girbino G, Grosso A, Latorre M, Maniscalco S, Mazza F, Mereu C, Molinengo G, Ora J, Paggiaro P, Patella V, Pelaia G, Pirina P, Proietto A, Rogliani P, Santus P, Scichilone N, Simioli F, Solidoro P, Terraneo S, Zuccon U, Canonica GW. Braido F, et al. Among authors: pelaia g. Pulm Pharmacol Ther. 2017 Jun;44:83-87. doi: 10.1016/j.pupt.2017.03.013. Epub 2017 Mar 21. Pulm Pharmacol Ther. 2017. PMID: 28341462
Higher blood eosinophil levels after omalizumab treatment may be associated with poorer asthma outcomes.
Sposato B, Scalese M, Milanese M, Masieri S, Cavaliere C, Latorre M, Scichilone N, Ricci A, Cresti A, Santus P, Olivieri C, Perrella A, Rogliani P, Paggiaro P; Omalizumab Italian Study Group. Sposato B, et al. J Allergy Clin Immunol Pract. 2019 May-Jun;7(5):1643-1646. doi: 10.1016/j.jaip.2019.03.006. Epub 2019 Mar 19. J Allergy Clin Immunol Pract. 2019. PMID: 30898690 No abstract available.
Mepolizumab effectiveness on small airway obstruction, corticosteroid sparing and maintenance therapy step-down in real life.
Sposato B, Camiciottoli G, Bacci E, Scalese M, Carpagnano GE, Pelaia C, Santus P, Maniscalco M, Masieri S, Corsico A, Scichilone N, Baglioni S, Murgia N, Folletti I, Bardi G, Grosso A, Cameli P, Latorre M, Musarra A, Bargagli E, Ricci A, Pelaia G, Paggiaro P, Rogliani P. Sposato B, et al. Among authors: pelaia g, pelaia c. Pulm Pharmacol Ther. 2020 Apr;61:101899. doi: 10.1016/j.pupt.2020.101899. Epub 2020 Jan 21. Pulm Pharmacol Ther. 2020. PMID: 31972327
Switching from omalizumab to mepolizumab: real-life experience from Southern Italy.
Carpagnano GE, Pelaia C, D'Amato M, Crimi N, Scichilone N, Scioscia G, Resta O, Calabrese C, Pelaia G, Quarato CMI, Foschino Barbaro MP. Carpagnano GE, et al. Among authors: pelaia g, pelaia c. Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620929231. doi: 10.1177/1753466620929231. Ther Adv Respir Dis. 2020. PMID: 32482128 Free PMC article.
205 results